DUALITYBIO-B (09606) issued a total of 78,100 shares upon exercise of share options.
DUALITYBIO-B (09606) announced that pursuant to the pre-IPO equity incentive plan adopted on February 28, 2021 and amended on June 25, 2023, 18,100 ordinary shares were issued upon the exercise of share options granted.
DUALITYBIO-B (09606) announced that pursuant to the pre-IPO equity incentive plan adopted on February 28, 2021 and amended on June 25, 2023, 18,100 ordinary shares were issued upon the exercise of share options granted.
Pursuant to the pre-IPO equity incentive plan adopted on February 28, 2021 and amended on June 25, 2023, 60,000 ordinary shares were issued upon the exercise of share options granted.
Related Articles
FSM HOLDINGS (01721) resolves to appoint KTC Hong Kong as the new auditor.
KNT HOLDINGS (01025): Zhuang Bin Retires as Executive Director
CIRC (01763) proposes appointing Li Penghui as an executive director of the fourth board of directors.
FSM HOLDINGS (01721) resolves to appoint KTC Hong Kong as the new auditor.
KNT HOLDINGS (01025): Zhuang Bin Retires as Executive Director
CIRC (01763) proposes appointing Li Penghui as an executive director of the fourth board of directors.
